In this second part of a two-part blog post, I’ll answer key questions about what’s ahead for The Alliance network and share my insights into how we are strategically seeking better ways to purchase high-value, safe health care for our members.
Read the first of a two-part Q&A with vice president of network development and provider relations Kyle Monroe about what’s ahead for provider contracting at The Alliance.
American Patients First, the Trump Administration’s “blueprint to lower drug prices,” contains provisions with the potential for a significant impact on the health care marketplace, according to Alex Jung, managing director in the Parthenon-EY practice of Ernst & Young LLP.
Onsite clinics are a growing trend for American employers. Today, 50 percent of employers with over 5,000 employees have onsite or near-site clinics, according to the National Association of Worksite Health Clinics. It’s predicted that in the next two years, this percentage will grow to two out of three.
“I want you [employers] to be the drivers of change,” said Heather Sundar, Pharm.D., senior vice president consulting and employer solutions at Archimedes. Sundar spoke at The Alliance’s September 2018 Annual Meeting about the risks and opportunities presented by specialty drugs and biosimilars.
Want to drop the total cost of care in your self-funded health benefit plan? One way to make a dramatic shift in both how much you’re paying and what you’re paying for is by implementing high-value primary care. The Alliance developed this infographic to help you quickly see the difference it can make.